AlphaCore Capital’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-230
Closed -$8.38K – 1249
2025
Q4
$8.38K Buy
+230
New +$8.62K ﹤0.01% 1327

Other funds holding BOUT

AlphaCore Capital's BOUT Position: Q1 2026 in Review

AlphaCore Capital sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q1 2026, closing a stake of 230 shares — an estimated $8.38K sold.

AlphaCore Capital first reported a position in BOUT in Q4 2025 and held it in 1 quarter. The position peaked at $8.38K in Q4 2025. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

  • AlphaCore Capital reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q1 2026 after selling out during the quarter.
  • AlphaCore Capital sold 230 CapForce IBD Breakout Opportunities ETF shares in Q1 2026, an estimated $8.38K.
  • AlphaCore Capital first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2025 and held it in 1 quarter.
  • AlphaCore Capital's CapForce IBD Breakout Opportunities ETF position peaked at $8.38K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.